As the science stands, the vast majority of the roughly eight million people in South Africa living with HIV will have to get ...
The BRAAVE2020 study investigated the efficacy of switching Black Americans living with HIV to a B/F/TAF single-pill regimen.
Immuno Cure’s ICVAX aims to induce broadly reactive polyfunctional viral-specific T cells to achieve sustained HIV-1 ...
A new study from Tulane University finds that historical race-based lending practices are still impacting health today, ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of new research data from its innovative HIV treatment ...
Due to positive results, the trial will conclude earlier than expected, reducing the number of recruitments. “These findings ...
Gilead is committed to designing trials to help understand how HIV treatment and prevention impact populations that have been ...
Gilead (GILD) announced the upcoming presentation of HIV research findings at the International Congress on Drug Therapy in HIV Infection, ...
News Medical on MSN1d
Historical redlining continues to affect HIV treatment in affected communitiesA new study from Tulane University finds that historical race-based lending practices are still impacting health today, linking these discriminatory policies to delays in effective HIV treatment ...
Specific subtypes and transmission clusters for HIV could require targeted interventions to control spread of HIV that is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback